Armin Szegedi, MD PhD in

Armin Szegedi, MD PhD

Examiner · DISC type cs
Chief Medical Officer at Sumitomo Pharma America, Inc.
📍 Rahway, New Jersey, United States

Armin Szegedi is the Chief Medical Officer at Sumitomo Pharma America, where he leverages his extensive experience in drug development. His expertise covers a broad range of disorders in psychiatry, neurology, pain, and anesthesia, built upon a foundation from his MD at Johannes Gutenberg University Mainz and leadership roles at Merck and Allergan.

He is a vocal advocate for advancing treatments for serious mental health conditions and has championed women in leadership roles. He frequently highlights team collaborations and their shared commitment to patients, particularly through partnerships with companies like Otsuka Pharmaceutical.

Unique fact: He has authored or co-authored more than 100 publications in peer-reviewed scientific journals.

Read the full overview →
Experience
22 Years
Current Role
Chief Medical Officer
Location
Rahway, New Jersey, United States
Personality Overview

How Armin shows up

Late Adopter
Unexpressive
Status Quo Seeker

They do not like taking risks at all and go for proven options in the end. They are heavily focused on quality and prefer doing things the right way, even if it takes time. They are always well-planned and adopt a systematic approach.

Priorities

Topics Armin cares about

CNS Drug Development
His career is dedicated to clinical development for psychiatry and neurology, having led CNS therapeutic areas at major pharmaceutical companies like Allergan and Merck.
Mental Health Advocacy
Frequently posts about advancing innovative treatments for conditions like bipolar disorder and working to eliminate the stigmas surrounding mental health.
+4 more topics Login to view topics
Career

Work history

7-2023 - 3-2024
Chief Medical Officer
Sumitomo Pharma America, Inc.
7-2020 - 6-2023
Senior Vice President and Chief Medical Officer
Sunovion Pharmaceuticals
3-2014 - 7-2020
Vice President Clinical Development CNS
Allergan
8-2012 - 12-2013
Executive Director Clinical Research
Merck
12-2009 - 8-2012
Section Head Psychiatry, Clinical Neurosciences; Clinical Lead Sugammadex (Bridion)
Merck
In the press

Media appearances

No media yetWe could not find public media appearances for this person.
Education
1985 - 2003
MD
Johannes Gutenberg University Mainz
Education details unavailable
Friedrich Woehler Gymnasium Singen
Social presence
in
Behavioral profile

DISC profile (public)

c

Calculativeness (C)

Calculativeness (C) reflects the degree to which a person is likely to be cautious, systematic and analytical. Those scoring high tend to emphasise quality and accuracy.

Other Sumitomo Pharma America, Inc. Employees

Explore more public profiles from related professionals.

More profiles

Discover additional public profiles from our index.

Unlock the full playbookSee exactly how to sell to Armin. Free, 10 seconds.